The profile of the human small intestinal microbiota remains to be uncovered primarily due to sampling difficulties.
Ileostomy provides the intestinal
luminal contents as
ileostomy effluents (IE) that offer opportunity for performing extensive analyses of nutrients, gastrointestinal fluids, metabolites, and microbiome. In the present study, we evaluated changes in the microbiome, pH, and bacterial
short-chain fatty acids (SCFAs) in IE obtained from patients who had undergone
ileostomy following surgical resection of
colon cancer and
inflammatory bowel disease (IBD). We enrolled 11 patients who varied in the duration of
ileostomy from 3 days to >5 years after surgery and had no
inflammation in the small intestine. The analyses suggested that IE from patients previously having IBD had less diversity and greater intraday and interday fluctuations, and increased pH and decreased levels of
propionic acid and
acetic acid than those in IE from patients previously having
cancer. Furthermore, correlation analysis suggested a possible effect of the intestinal microbiome on
luminal pH, presumably via SCFA production. The present study suggested that
inflammation in the colon may induce long-term
dysbiosis in the small intestine even after removal of diseased parts of the colon. Moreover,
pharmaceutical-grade Japanese
traditional medicine daikenchuto (TU-100) was found to have beneficial effects on postoperative bowel dysfunction and the human small intestinal microbiota. Taken together, these results suggest the necessity of a direct remedy for
dysbiosis and the treatment of gastrointestinal lesions to achieve favorable outcomes for chronic
gastrointestinal disorders.